Bioventus ($BVS) Insider Trading & Smart Money Activity

Bioventus Inc. · Medical Devices · Latest filing Jun 30, 2026

Bioventus Inc. ($BVS) has 3 analyst ratings on file.

Insider buyers (12 mo)

0

Insider sellers (12 mo)

0

Net insider $ (12 mo)

$0

Congress trades (12 mo)

0

13F moves on file

0

Analyst ratings on file

3

BVS insider buying and selling by quarter

Quarter	Insider buys	Insider sales	Congress buys / sales	13F added / cut
Q1 2026	0	0	0 / 0	0 / 0
Q2 2026	0	0	0 / 0	0 / 0
Q3 2026	0	0	0 / 0	0 / 0
Q4 2026	0	0	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All BVS insider, congress, 13F and analyst activity

All Analysts

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	6M	Filing	Story
Jun 30, 2026	Analyst	Barrington Research	Reiterates to buy		PT $14		+21.7%	+39.6%			Read
Jun 16, 2026	Analyst	Canaccord Genuity	Reiterates to buy		PT $15		+6.5%	+42.5%			Read
Jun 16, 2026	Analyst	Canaccord Genuity	Reiterates to buy		PT $15		+6.5%	+42.5%			Read

1W / 1M / 6M = how BVS moved from the trade or filing date.

Analyst ratings on BVS

Date	Firm	Action	Rating	Price target	1W	1M	6M	Story
Jun 30, 2026	Barrington Research	Reiterates	buy	$14	+21.7%	+39.6%		Read
Jun 16, 2026	Canaccord Genuity	Reiterates	buy	$15	+6.5%	+42.5%		Read
Jun 16, 2026	Canaccord Genuity	Reiterates	buy	$15	+6.5%	+42.5%		Read

Other medical devices stocks

• $CBLL
• $SIBN
• $AHCO
• $PRCT
• $IRMD
• $QDEL
• $ENOV
• $TNDM

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.